Considering all the aforementioned reports, we then hypothesize in the current study that JMJD2C may participate in the regulation of CDDP resistance in uveal melanoma, with the involvement of the MDM2/p53/IL5RA axis. The gene discussed is TP53; the disease is uveal melanoma.